We build the analytics precision medicine companies grow on.

Lab test results show where precision medicine demand is forming, earlier and more specifically than claims. Hyperdrive resolves that data to the individual provider and puts it to work for commercial teams.

  • 50+

    Client engagements

  • 1.8M+

    Providers mapped

  • 3.8M+

    New patient cases a year, across indications

  • 6M+

    Lab test orders and results a year

What we do

One foundation, five ways to work with us

Everything we do runs on the same foundation: resolved diagnostic data and the systems that make it usable.


Who we serve

Three industries, one resolved market


Technology partnerships

Your product, our technology

We build products with our partners and stay on as the technology behind them: platforms under your brand, and AI agents working inside your sales and engagement workflows.

Case: Boca BioSpecimen360

Boca Bio needed a way for researchers to search a biospecimen catalog the way a buyer actually thinks about it: by sample type, matrix, test characterization and the assay results attached to each specimen.

We collaborated with Boca Bio to build BioSpecimen360, which runs as their own branded product with Hyperdrive as the trusted technology partner. Over 360,000 banked biospecimens are available for purchase on the platform today. The same resolution and enrichment work behind Voyager, applied to a different problem.

Read Boca Bio's announcement →

Boca BioSpecimen360 biospecimen search: filtered lung cancer plasma specimens with EGFR L858R results, a selection panel showing whole slide images, NGS data and test results, and a filterable dashboard

How we work

We take on the problems that do not have a clean answer yet

The hard part in this space is rarely the software. It is that provider identity is messy, laboratory data does not arrive in a standard shape, and the commercial question underneath is usually more specific than any off-the-shelf product allows for. Those are the problems we like.

Our team works in diagnostics, precision medicine and sales enablement every day. We know what a pathology report contains, what an NPI does and does not tell you, and what a field team needs in order to act on a Monday morning. Engagements start from that fluency rather than building toward it.

  • Diagnostics
  • Precision medicine
  • Sales enablement
  • Laboratory data
  • Commercial strategy

Advisory

Real-world data workshops, go-to-market and AI strategy

Working sessions built around your data and your commercial question, not a general overview of the RWD landscape. What the data can answer today, where the gaps are, and what closing them is worth. We also help commercial teams bring agentic workflows into sales enablement and customer engagement: which processes to hand to AI agents first, and where a person should stay in the loop.

Reference laboratory

A national oncology reference laboratory had begun bringing TEFCA HIE data into their warehouse. We ran a strategy workshop that walked their team through a prioritization matrix of the valuable problems that data asset could solve, and where to put it to work across the enterprise for informatics revenue.

Digital pathology

A leading digital pathology company wanted to turn their sourced network data into data services revenue. We ran a workshop on how pharma buys laboratory data for alerts and triggers, then gave them clear next steps to operationalize it quickly, org charts and selling motion included.

Go-to-market

Diagnostics startups and reference laboratories looking to grow into new markets. Go-to-market strategy work on where the demand actually sits, which accounts to pursue first, and what it takes to reach them.


Questions

Common questions about Hyperdrive Bio

What does Hyperdrive Bio do?

Hyperdrive Bio builds the data systems precision medicine companies grow on. We resolve diagnostic and laboratory data to the individual provider and organization, run the Voyager platform and the Lab Data Network, deliver commercial analytics to biopharma, build technology products with partners, and advise teams on commercial data strategy.

Who does Hyperdrive work with?

Biopharma brand and field teams, reference laboratories and diagnostics companies. Biopharma uses Hyperdrive to find providers with treatment-eligible patients, reference labs to monetize their data and target their sales, and diagnostics companies to see what each lab bills Medicare for testing and find the pathologists in their market.

Where does Hyperdrive's data come from?

From the Lab Data Network, a select group of clinical, pathology and genomics laboratories that supply de-identified testing data directly. The network covers more than 6 million laboratory test orders and results and 3.8 million new patient cases a year across indications, summarized to the individual healthcare provider.

What is Voyager?

Voyager is Hyperdrive's commercial analytics and sales enablement platform. Teams use it to build targeted lists of hospitals, physician groups, laboratories and specialty providers, enrich them with verified contact detail, and work them as leads with notes, reports and sales routes, or export them to their CRM.

What is Hyperdrive commercial analytics?

A set of solutions for biopharma brand and precision medicine teams, built on proprietary laboratory testing and biomarker data from the Hyperdrive Lab Data Network. They include HCP alerts, patient finding, testing gap analytics, market landscaping, targeting and territory planning, delivered as prospective weekly data with lookbacks or as custom analyses.

Can Hyperdrive build a platform under our brand?

Yes. When the product you need does not exist yet, we build it with you and stay on as the technology partner. Boca Bio's BioSpecimen360, which lists more than 360,000 banked biospecimens, runs under Boca Bio's brand on Hyperdrive technology.


Get started

Tell us what you are trying to do

If it is Voyager, give us a brand and a geography and we will run it live against real accounts and providers, on data you can check. The target list we build on the call is yours to keep. If it is a build, or a question about what your data can support, the conversation starts the same way.